Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $3.2 million.

  • Agilon Health's Capital Expenditures fell 1015.85% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year decrease of 270.89%. This contributed to the annual value of $13.3 million for FY2024, which is 1629.19% down from last year.
  • Agilon Health's Capital Expenditures amounted to $3.2 million in Q3 2025, which was down 1015.85% from $3.2 million recorded in Q2 2025.
  • Agilon Health's Capital Expenditures' 5-year high stood at $4.5 million during Q2 2022, with a 5-year trough of $178000.0 in Q1 2021.
  • Over the past 5 years, Agilon Health's median Capital Expenditures value was $3.4 million (recorded in 2022), while the average stood at $3.2 million.
  • In the last 5 years, Agilon Health's Capital Expenditures plummeted by 4840.58% in 2021 and then soared by 217471.91% in 2022.
  • Quarter analysis of 5 years shows Agilon Health's Capital Expenditures stood at $3.4 million in 2021, then grew by 2.62% to $3.5 million in 2022, then rose by 12.7% to $3.9 million in 2023, then dropped by 16.94% to $3.3 million in 2024, then dropped by 2.79% to $3.2 million in 2025.
  • Its Capital Expenditures was $3.2 million in Q3 2025, compared to $3.2 million in Q2 2025 and $3.8 million in Q1 2025.